节点文献

脂联素防治糖尿病心肌病的研究进展

Research progress on prevention and treatment of adiponectin in diabetic cardiomyopathy

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 吴霞吴学厅黄磊涛周学亮陶恩德刘季春

【Author】 WU Xia;WU Xue-ting;HUANG Lei-tao;ZHOU Xue-liang;TAO En-de;LIU Ji-chun;Department of Thoracic and Cardiovascular Surgery,the First Affiliated Hospital of Nanchang University;Family Planning Service Station;Department of Orthopedics,the Fourth Affiliated Hospital of Nanjing Medical University;Department of Cardiac Surgery,Wuhan Asia Heart Hospital;

【通讯作者】 刘季春;

【机构】 南昌大学第一附属医院胸心外科河南省项城市计划生育服务站南京医科大学第四附属医院骨科武汉亚洲心脏病医院心脏外科

【摘要】 糖尿病心肌病(diabetic cardiomyopathy, DCM)是一种基于糖尿病,排除心脏本身疾病导致的独立的缺血性心肌疾病。DCM的发病机制由多因素造成,目前并不十分明确,其主要由心肌细胞的损伤、血糖浓度增高、能量代谢紊乱及微血管病变引起。脂联素(adiponectin, APN)具有降血糖、调血脂、抗凋亡、抗炎症反应、抗氧化作用,也能预防动脉粥样硬化,与DCM的发生发展具有密切关系。本文就APN在DCM中作用的研究进展作一综述。

【Abstract】 Diabetic cardiomyopathy(DCM) is an independent ischemic heart disease that occurs on the basis of diabetes, excluding diseases originated from the heart itself. The pathogenesis of DCM is caused by multiple factors and is still not well elucidated. It involves the injury of cardiac myocytes, hyperglycemia, energy metabolism disorder, and cardiac microvascular disease. Adiponectin(APN) has been found to be able to reduce the level of glycemia and regulate blood lipids, and has anti-apoptotic, anti-inflammatory, and antioxidant properties, as also be able to prevent atherosclerosis, and has close relationship with the development of DCM. Therefore, this article describes and summarizes the role of adiponectin in DCM.

【基金】 国家自然科学基金面上项目(00019509);江西省科技厅-领军人才培养计划(赣鄱英才555工程)(700207004)~~
  • 【文献出处】 中国临床医学 ,Chinese Journal of Clinical Medicine , 编辑部邮箱 ,2019年01期
  • 【分类号】R587.2;R542.2
  • 【被引频次】4
  • 【下载频次】305
节点文献中: 

本文链接的文献网络图示:

本文的引文网络